Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Impact of Ketamine on Epigenetic Age (IKEA)
Authors not listed
TruDiagnostic · 2022
Abstract
This is a prospective, clinical pilot study (n=20) to evaluate the impact of a ketamine treatment for Major Depressive Disorder (MDD) or Post Traumatic Stress Disorder (PTSD) on epigenetic aging by the TruAge epigenetic age laboratory test.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Anonymous. (2022). Impact of Ketamine on Epigenetic Age (IKEA). <em>TruDiagnostic</em>. https://clinicaltrials.gov/study/NCT05294835
Vancouver
Anonymous. Impact of Ketamine on Epigenetic Age (IKEA). TruDiagnostic. 2022.
BibTeX
@misc{anon2022Impact,
title = {Impact of Ketamine on Epigenetic Age (IKEA)},
author = {Anonymous},
journal = {TruDiagnostic},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational Psychiatry 2025
Open access · CC-BY
Epigenetic aging and DNA methylation biomarker changes following ketamine treatment in patients with MDD and PTSD: a pilot study
Lesaffre International 2025
Open access · US-GOV
Clinical Trial Investigating the Relationship Between Skin Microbiome, Epigenetic Biological Age and Facial Morphological Features in Aging Context
medRxiv 2024
Preprint · CC-BY
Ketamine treatment effects on DNA methylation and Epigenetic Biomarkers of aging
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 2025
Open access · US-GOV
Development of Epigenetic Clocks to Predict Ovarian Aging and Live Birth Rate in Assisted Reproduction Technology Procedures
Psychological Medicine 2018
Preprint · OA
Posttraumatic psychopathology and the pace of the epigenetic clock: a longitudinal investigation
Elysium Health 2019
Open access · US-GOV